MIR5586

Across TCGA pan-cancer cohorts, MIR5586 RNA differs between tumor and matched normal tissue in 1 of 18 cancer types tested, making tumor–normal expression one of MIR5586’s most consistent transcriptional readouts.

The strongest signal is observed in prostate adenocarcinoma (PRAD), where MIR5586 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types MIR5586 is over-expressed in tumor.

PRAD are the cancer types where MIR5586 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in MIR5586 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
PRAD	All	All	+0.083	.047	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 1 strongest of 1 lineages.

MIR5586–PRAD

Open the PRAD breakdown →